nach oben

Journal of Endocrinological Investigation

Erschienen in:

01.07.2020 | Comment

COVID-19 and the endocrine system: exploring the unexplored

verfasst von: R. Pal, M. Banerjee

Erschienen in: Journal of Endocrinological Investigation | Ausgabe 7/2020

Einloggen, um Zugang zu erhalten

Excerpt

A novel coronavirus disease (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has affected over 2.3 million people, claiming more than 160000 lives in over 200 countries worldwide. Although COVID-19 can be asymptomatic, the primary presentation in symptomatic patients is in the form of viral pneumonia, sometimes complicated by acute respiratory distress syndrome and/or sepsis. In addition, myocarditis and acute kidney injury have also been described in COVID-19. On the contrary, endocrinological manifestations have not yet been reported in patients with COVID-19. …

Chang L, Yan Y, Wang L (2020) Coronavirus disease 2019: coronaviruses and blood safety. Transfus Med Rev [Internet] [cited 2020 Apr 1]; Available from: https://linkinghub.elsevier.com/retrieve/pii/S0887796320300146. Accessed 1 Apr 2020

Liu F, Long X, Zou W, Fang M, Wu W, Li W, et al. (2020) Highly ACE2 expression in pancreas may cause pancreas damage after SARS-CoV-2 infection [Internet] [cited 2020 Apr 1]. Available from: https://medrxiv.org/lookup/doi/10.1101/2020.02.28.20029181. Accessed 1 Apr 2020

Yang JK, Feng Y, Yuan MY, Yuan SY, Fu HJ, Wu BY et al (2006) Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS. Diabet Med 23:623–628CrossRef

Yang J-K, Lin S-S, Ji X-J, Guo L-M (2010) Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes. Acta Diabetol 47:193–199CrossRef

Ding Y, He L, Zhang Q, Huang Z, Che X, Hou J et al (2004) Organ distribution of severe acute respiratory syndrome(SARS) associated coronavirus(SARS-CoV) in SARS patients: implications for pathogenesis and virus transmission pathways. J Pathol 203:622–630CrossRef

Jaeckel E, Manns M, Herrath M (2006) Viruses and diabetes. Ann N Y Acad Sci 958:7–25CrossRef

Wan J, Sun W, Li X, Ying W, Dai J, Kuai X et al (2006) Inflammation inhibitors were remarkably up-regulated in plasma of severe acute respiratory syndrome patients at progressive phase. Proteomics 6:2886–2894CrossRef

Pal R, Bhansali A (2020) COVID-19, diabetes mellitus and ACE2: the conundrum. Diabetes Res Clin Pract 162:108132CrossRef

Guo W, Li M, Dong Y, Zhou H, Zhang Z, Tian C et al (2020) Diabetes is a risk factor for the progression and prognosis of COVID-19. Diabetes Metab Res Rev 7:e3319CrossRef

10.

Coronavirus COVID-19 FAQ | ADA. Accessed April 21, 2020. [Internet]. Available from: https://www.diabetes.org/covid-19-faq. Accessed 21 Apr 2020

11.

Zhang W, Xu Y-Z, Liu B, Wu R, Yang Y-Y, Xiao X-Q et al (2014) Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis. Sci World J 2014:1–7

12.

Romaní-Pérez M, Outeiriño-Iglesias V, Moya CM, Santisteban P, González-Matías LC, Vigo E et al (2015) Activation of the GLP-1 receptor by liraglutide increases ACE2 expression, reversing right ventricle hypertrophy, and improving the production of SP-A and SP-B in the lungs of type 1 diabetes rats. Endocrinology 156:3559–3569CrossRef

13.

Pal R, Bhadada SK (2020) Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Diabetes Res Clin Pract 163:108146CrossRef

14.

Kassir R (2020) Risk of COVID-19 for patients with obesity. Obes Rev [Internet] [cited 2020 Apr 22]; Available from: https://doi.wiley.com/10.1111/obr.13034. Accessed 22 Apr 2020

15.

Richard C, Wadowski M, Goruk S, Cameron L, Sharma AM, Field CJ (2017) Individuals with obesity and type 2 diabetes have additional immune dysfunction compared with obese individuals who are metabolically healthy. BMJ Open Diabetes Res Care 5:e000379CrossRef

16.

Sanyal D, Raychaudhuri M (2016) Hypothyroidism and obesity: an intriguing link. Indian J Endocrinol Metab 20:554CrossRef

17.

Fernandez CJ, Chacko EC, Pappachan JM (2019) Male obesity-related secondary hypogonadism—pathophysiology. Clinical Implications and Management. Eur Endocrinol 15:83CrossRef

18.

Ma L, Xie W, Li D, Shi L, Mao Y, Xiong Y, et al. (2020) Effect of SARS-CoV-2 infection upon male gonadal function: a single center-based study [Internet] [cited 2020 Apr 2]. Available from: https://medrxiv.org/lookup/doi/10.1101/2020.03.21.20037267. Accessed 2 Apr 2020

19.

Xu J, Qi L, Chi X, Yang J, Wei X, Gong E et al (2006) Orchitis: a complication of severe acute respiratory syndrome (SARS)1. Biol Reprod 74:410–416CrossRef

20.

Channappanavar R, Fett C, Mack M, Ten Eyck PP, Meyerholz DK, Perlman S (2017) Sex-based differences in susceptibility to severe acute respiratory syndrome coronavirus infection. J Immunol 198:4046–4053CrossRef

21.

Wheatland R (2004) Molecular mimicry of ACTH in SARS—implications for corticosteroid treatment and prophylaxis. Med Hypotheses 63:855–862CrossRef

22.

Xu J, Zhao S, Teng T, Abdalla AE, Zhu W, Xie L et al (2020) Systematic comparison of two animal-to-human transmitted human coronaviruses: SARS-CoV-2 and SARS-CoV. Viruses 12:244CrossRef

23.

Zha L, Li S, Pan L, Tefsen B, Li Y, French N, et al. (2020) Corticosteroid treatment of patients with coronavirus disease 2019 (COVID-19). Med J Aust [Internet] [cited 2020 Apr 22]; Available from: https://doi.wiley.com/10.5694/mja2.50577. Accessed 22 Apr 2020

24.

Brann DH, Tsukahara T, Weinreb C, Logan DW, Datta SR (2020) Non-neural expression of SARS-CoV-2 entry genes in the olfactory epithelium suggests mechanisms underlying anosmia in COVID-19 patients [Internet] [cited 2020 Apr 2]. Available from: https://biorxiv.org/lookup/doi/10.1101/2020.03.25.009084. Accessed 2 Apr 2020

25.

Leow MK-S, Kwek DS-K, Ng AW-K, Ong K-C, Kaw GJ-L, Lee LS-U (2005) Hypocortisolism in survivors of severe acute respiratory syndrome (SARS). Clin Endocrinol (Oxf) 63:197–202CrossRef

26.

Kaiser UB, Mirmira RG, Stewart PM (2020) Our Response to COVID-19 as Endocrinologists and Diabetologists. J Clin Endocrinol Metab [Internet] [cited 2020 Apr 16];105. Available from: https://academic.oup.com/jcem/article/doi/10.1210/clinem/dgaa148/5814115. Accessed 16 Apr 2020

27.

De Jongh F, Jobsis A, Elte J (2001) Thyroid morphology in lethal non-thyroidal illness: a post-mortem study. Eur J Endocrinol 144:221–226CrossRef

28.

Wei L, Sun S, Xu C, Zhang J, Xu Y, Zhu H et al (2007) Pathology of the thyroid in severe acute respiratory syndrome. Hum Pathol 38:95–102CrossRef

Titel: COVID-19 and the endocrine system: exploring the unexplored
verfasst von: R. Pal
M. Banerjee
Publikationsdatum: 01.07.2020
Verlag: Springer International Publishing
Erschienen in: Journal of Endocrinological Investigation / Ausgabe 7/2020
Elektronische ISSN: 1720-8386
DOI: https://doi.org/10.1007/s40618-020-01276-8

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

19.04.2024 | Vorhofflimmern | Nachrichten

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

COVID-19 and the endocrine system: exploring the unexplored

Excerpt

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin

Live-Webinar: Aktuelle Leitlinien bei Herz-Kreislauf-Erkrankungen

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 7/2020

The haemostatic system in acromegaly: a single-centre case–control study

Impact of using different biomarkers of liver fibrosis on hepatologic referral of individuals with severe obesity and NAFLD

Tear inflammatory cytokines and ocular surface changes in patients with active thyroid eye disease treated with high-dose intravenous glucocorticoids

Occurrence of Graves’ hyperthyroidism and Graves’ orbitopathy after fine-needle aspiration biopsy of thyroid nodules

The Italian Endo-COVID-19. Our response to the emergency

In memory of Giulio Giordano

Leitlinien kompakt für die Innere Medizin

Neu im Fachgebiet Innere Medizin

Parodontalbehandlung verbessert Prognose bei Katheterablation

Prostatakarzinom: EU initiiert neues Screeningkonzept

Blasenkarzinom – Biomarker statt Zytologie?

Antihypertensiva schützen auch alte Menschen noch vor Demenz

Update Innere Medizin